Covid-19 Vaccine Corbevax
- All
- News
- Videos
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
- Tuesday January 16, 2024
- India News | Press Trust of India
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
- www.ndtv.com
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
- Thursday August 11, 2022
- India News | Press Trust of India
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
- www.ndtv.com
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
- Wednesday August 10, 2022
- India News | Press Trust of India
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
- www.ndtv.com
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
- Saturday June 4, 2022
- India News | Edited by Debanish Achom
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
- www.ndtv.com
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
- Monday May 16, 2022
- India News | Press Trust of India
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
- www.ndtv.com
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
- Wednesday March 16, 2022
- India News | Edited by Debanish Achom
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
- www.ndtv.com
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
- Tuesday March 15, 2022
- Education | Reported by Press Trust of India
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
- www.ndtv.com/education
-
Centre Releases Guidelines For Covid Vaccination Of 12-14 Age Group
- Tuesday March 15, 2022
- India News | Press Trust of India
The Centre today released guidelines for COVID-19 vaccination of children between 12-14 years that will begin from March 16 and said only Corbevax vaccine would be used for the beneficiaries of this age group.
- www.ndtv.com
-
Influential US Congress Members Urge Vaccine Collaboration With India
- Saturday March 12, 2022
- India News | Press Trust of India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
- www.ndtv.com
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
- Monday February 21, 2022
- India News | Edited by Debanish Achom
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
- www.ndtv.com
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
- Tuesday December 28, 2021
- India News | Press Trust of India
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
- www.ndtv.com
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
- Tuesday December 28, 2021
- India News | Edited by Debanish Achom
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
- www.ndtv.com
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
- Monday October 25, 2021
- India News | Press Trust of India
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
- www.ndtv.com
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
- Tuesday October 12, 2021
- India News | Press Trust of India
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
- www.ndtv.com
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
- Friday September 3, 2021
- India News | Press Trust of India
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
- www.ndtv.com
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
- Tuesday January 16, 2024
- India News | Press Trust of India
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
- www.ndtv.com
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
- Thursday August 11, 2022
- India News | Press Trust of India
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
- www.ndtv.com
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
- Wednesday August 10, 2022
- India News | Press Trust of India
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
- www.ndtv.com
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
- Saturday June 4, 2022
- India News | Edited by Debanish Achom
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
- www.ndtv.com
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
- Monday May 16, 2022
- India News | Press Trust of India
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
- www.ndtv.com
-
Corbevax For Children To Cost Rs 800 In Market, Rs 145 For Government
- Wednesday March 16, 2022
- India News | Edited by Debanish Achom
The Corbevax COVID-19 vaccine for those aged 12 to 14 will cost Rs 800 in the market before taxes, sources have said. It will be sold to the government at Rs 145, the lowest in the world.
- www.ndtv.com
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
- Tuesday March 15, 2022
- Education | Reported by Press Trust of India
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
- www.ndtv.com/education
-
Centre Releases Guidelines For Covid Vaccination Of 12-14 Age Group
- Tuesday March 15, 2022
- India News | Press Trust of India
The Centre today released guidelines for COVID-19 vaccination of children between 12-14 years that will begin from March 16 and said only Corbevax vaccine would be used for the beneficiaries of this age group.
- www.ndtv.com
-
Influential US Congress Members Urge Vaccine Collaboration With India
- Saturday March 12, 2022
- India News | Press Trust of India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
- www.ndtv.com
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
- Monday February 21, 2022
- India News | Edited by Debanish Achom
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
- www.ndtv.com
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
- Tuesday December 28, 2021
- India News | Press Trust of India
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
- www.ndtv.com
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
- Tuesday December 28, 2021
- India News | Edited by Debanish Achom
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
- www.ndtv.com
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
- Monday October 25, 2021
- India News | Press Trust of India
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
- www.ndtv.com
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
- Tuesday October 12, 2021
- India News | Press Trust of India
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
- www.ndtv.com
-
Biological E Gets Nod For Further Trials Of Its Covid Vaccine On Children
- Friday September 3, 2021
- India News | Press Trust of India
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
- www.ndtv.com